This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated FOXC1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-FOXC1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~56.8 kDa | |
| Observed band | Approximately 75 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated + Ubiquitinated | |
| Caveat | Phosphorylation-induced mobility shift | |
| Regulation | Estrogen up | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for FOXC1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human 293T . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-FOXC1 antigen affinity purified polyclonal antibody (A00962-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for FOXC1 at approximately 75 kDa. The expected band size for FOXC1 is at 53 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 75 kDa |
FOXC1 has a 56.8 kDa predicted backbone but runs at approximately 75 kDa on Western blot, mainly due to phosphorylation and Ubl conjugation, not glycosylation or dimerization.
| Single band at approximately 75 kDa in nuclear or whole-cell lysate | This is the expected native FOXC1 band; it runs well above the 56.8 kDa predicted mass due to post-translational modification rather than a distinct species |
| No band near twice the predicted mass | FOXC1 functions as a monomer with no annotated inter-chain disulfide bonds, so a dimer-sized band is not expected |
| Single band, no doublet or ladder of isoform-sized bands | Only one FOXC1 isoform is annotated, so multiple isoform-driven bands are not expected |
| No smaller fragment well below the ~57 kDa predicted backbone | FOXC1 has no signal peptide or propeptide, so there is no smaller cleaved/mature product to look for |
| Sharp, well-resolved band rather than a smear | FOXC1 has no annotated glycosylation sites, so the band should stay sharp rather than smearing like a heterogeneously glycosylated protein |
| Band detected in nuclear-enriched or whole-cell lysate, not in culture supernatant | FOXC1 is a nuclear transcription factor, not a secreted protein, so signal is expected in cell lysates rather than conditioned media |
| Predicted mass (UniProt, 56.8 kDa / 553 aa) | Sets the baseline unmodified-backbone expectation that the observed native band runs above |
| Phosphorylation (5 annotated phosphoserine sites, e.g. Ser235, Ser241, Ser272) | Marks FOXC1 as a phosphoprotein; phosphorylated species commonly migrate more slowly than the unmodified backbone, shifting the apparent band upward |
| Ubl (ubiquitin-like) conjugation | Covalent attachment of a ubiquitin-like modifier adds mass to a portion of the protein pool, pushing its apparent size above the predicted 56.8 kDa |
| Monomer with no annotated disulfide bonds | No inter-chain disulfide-linked dimer forms, so the band should not double under non-reducing conditions |
| Single annotated isoform | No alternate splice forms exist to generate additional bands at different sizes |
| No signal peptide or propeptide | No proteolytic maturation step occurs, so no smaller cleaved fragment is expected relative to full-length FOXC1 |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | FOXC1 is nuclear-localized, so standard whole-cell lysis that under-solubilizes the nuclear compartment can leave it under-extracted | Use a lysis protocol with adequate nuclear extraction (e.g., RIPA with sonication or a nuclear extraction kit) and load a nuclear-enriched fraction |
| Band higher than expected | Phosphorylation and Ubl conjugation shift FOXC1's apparent mass above the 56.8 kDa predicted backbone, producing the ~75 kDa band seen on QC blots | Treat the ~75 kDa band as the expected native signal rather than comparing directly to the calculated 56.8 kDa mass |
| Band lower than expected | Bacterially expressed recombinant FOXC1 lacks phosphorylation and Ubl conjugation, so it runs closer to the 56.8 kDa predicted mass | Compare lysate samples to a mammalian-expressed or native positive control rather than a bacterial recombinant standard |
| Multiple bands | Partial phosphorylation or Ubl conjugation across the FOXC1 pool can produce closely spaced bands instead of one uniform species | Treat lysate with phosphatase to collapse modification-driven bands and confirm the single predicted backbone species |
| Weak or no signal | FOXC1 is a lower-abundance nuclear transcription factor, so low-expressing cell lines or insufficient nuclear enrichment give weak signal | Increase protein loading, use a nuclear extraction protocol, and confirm expression in a known FOXC1-positive line |
| Fragments below expected size | FOXC1 has no annotated propeptide or signal peptide, so smaller fragments are not a normal maturation product and instead suggest degradation | Add protease inhibitors during lysis and keep samples cold throughout preparation to prevent degradation artifacts |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for FOXC1, answered from its protein features.
BosterBio's FOXC1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-FOXC1 antibody is a best-performing, extensively cited reagent, rigorously validated by western blot and orthogonally cross-validated against negative-control tissues and complementary detection methods, ensuring specific, reproducible detection of FOXC1 across experimental systems.
Which to pick: Only one Boster FOXC1 antibody is catalogued, A00962-2, which includes an actual western blot validation image demonstrating specific detection—making it the clear default choice for your FOXC1 western blot experiments.